Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Regenerative Therapies for Osteoarthritis Revenue 1.4 Market Analysis by Type 1.4.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Cell Therapy 1.4.3 Tissue Engineering 1.4.4 Gene Therapy 1.5 Market by Application 1.5.1 Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Ambulatory Surgical Centers 1.5.4 Orthopaedic Clinics 1.5.5 Research Institutes 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Regenerative Therapies for Osteoarthritis Market Perspective (2015-2026) 2.2 Regenerative Therapies for Osteoarthritis Growth Trends by Regions 2.2.1 Regenerative Therapies for Osteoarthritis Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Regenerative Therapies for Osteoarthritis Historic Market Share by Regions (2015-2020) 2.2.3 Regenerative Therapies for Osteoarthritis Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Regenerative Therapies for Osteoarthritis Market Growth Strategy 2.3.6 Primary Interviews with Key Regenerative Therapies for Osteoarthritis Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Regenerative Therapies for Osteoarthritis Players by Market Size 3.1.1 Global Top Regenerative Therapies for Osteoarthritis Players by Revenue (2015-2020) 3.1.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Players (2015-2020) 3.1.3 Global Regenerative Therapies for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio 3.2.1 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Regenerative Therapies for Osteoarthritis Revenue in 2019 3.3 Regenerative Therapies for Osteoarthritis Key Players Head office and Area Served 3.4 Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service 3.5 Date of Enter into Regenerative Therapies for Osteoarthritis Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Type (2015-2020) 4.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2021-2026) 5 Regenerative Therapies for Osteoarthritis Breakdown Data by Application (2015-2026) 5.1 Global Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 5.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 6.2 Regenerative Therapies for Osteoarthritis Key Players in North America (2019-2020) 6.3 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 6.4 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 7 Europe 7.1 Europe Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 7.2 Regenerative Therapies for Osteoarthritis Key Players in Europe (2019-2020) 7.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 7.4 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 8 China 8.1 China Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 8.2 Regenerative Therapies for Osteoarthritis Key Players in China (2019-2020) 8.3 China Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 8.4 China Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 9 Japan 9.1 Japan Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 9.2 Regenerative Therapies for Osteoarthritis Key Players in Japan (2019-2020) 9.3 Japan Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 9.4 Japan Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 10.2 Regenerative Therapies for Osteoarthritis Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 10.4 Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 11 India 11.1 India Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 11.2 Regenerative Therapies for Osteoarthritis Key Players in India (2019-2020) 11.3 India Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 11.4 India Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Regenerative Therapies for Osteoarthritis Market Size (2015-2020) 12.2 Regenerative Therapies for Osteoarthritis Key Players in Central & South America (2019-2020) 12.3 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) 12.4 Central & South America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Acelity 13.1.1 Acelity Company Details 13.1.2 Acelity Business Overview and Its Total Revenue 13.1.3 Acelity Regenerative Therapies for Osteoarthritis Introduction 13.1.4 Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020)) 13.1.5 Acelity Recent Development 13.2 Mesoblast 13.2.1 Mesoblast Company Details 13.2.2 Mesoblast Business Overview and Its Total Revenue 13.2.3 Mesoblast Regenerative Therapies for Osteoarthritis Introduction 13.2.4 Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.2.5 Mesoblast Recent Development 13.3 Nuo Therapeutics 13.3.1 Nuo Therapeutics Company Details 13.3.2 Nuo Therapeutics Business Overview and Its Total Revenue 13.3.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Introduction 13.3.4 Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.3.5 Nuo Therapeutics Recent Development 13.4 Astellas Pharma 13.4.1 Astellas Pharma Company Details 13.4.2 Astellas Pharma Business Overview and Its Total Revenue 13.4.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Introduction 13.4.4 Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.4.5 Astellas Pharma Recent Development 13.5 Organovo 13.5.1 Organovo Company Details 13.5.2 Organovo Business Overview and Its Total Revenue 13.5.3 Organovo Regenerative Therapies for Osteoarthritis Introduction 13.5.4 Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.5.5 Organovo Recent Development 13.6 Orgenesis 13.6.1 Orgenesis Company Details 13.6.2 Orgenesis Business Overview and Its Total Revenue 13.6.3 Orgenesis Regenerative Therapies for Osteoarthritis Introduction 13.6.4 Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.6.5 Orgenesis Recent Development 13.7 Sanofi 13.7.1 Sanofi Company Details 13.7.2 Sanofi Business Overview and Its Total Revenue 13.7.3 Sanofi Regenerative Therapies for Osteoarthritis Introduction 13.7.4 Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.7.5 Sanofi Recent Development 13.8 Athersys 13.8.1 Athersys Company Details 13.8.2 Athersys Business Overview and Its Total Revenue 13.8.3 Athersys Regenerative Therapies for Osteoarthritis Introduction 13.8.4 Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.8.5 Athersys Recent Development 13.9 Takeda 13.9.1 Takeda Company Details 13.9.2 Takeda Business Overview and Its Total Revenue 13.9.3 Takeda Regenerative Therapies for Osteoarthritis Introduction 13.9.4 Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.9.5 Takeda Recent Development 13.10 Cytori Therapeutics 13.10.1 Cytori Therapeutics Company Details 13.10.2 Cytori Therapeutics Business Overview and Its Total Revenue 13.10.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Introduction 13.10.4 Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) 13.10.5 Cytori Therapeutics Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Regenerative Therapies for Osteoarthritis Key Market Segments Table 2. Key Players Covered: Ranking by Regenerative Therapies for Osteoarthritis Revenue Table 3. Ranking of Global Top Regenerative Therapies for Osteoarthritis Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Cell Therapy Table 6. Key Players of Tissue Engineering Table 7. Key Players of Gene Therapy Table 8. Global Regenerative Therapies for Osteoarthritis Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Regenerative Therapies for Osteoarthritis Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Regenerative Therapies for Osteoarthritis Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2015-2020) Table 12. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Regenerative Therapies for Osteoarthritis Market Growth Strategy Table 18. Main Points Interviewed from Key Regenerative Therapies for Osteoarthritis Players Table 19. Global Regenerative Therapies for Osteoarthritis Revenue by Players (2015-2020) (Million US$) Table 20. Global Regenerative Therapies for Osteoarthritis Market Share by Players (2015-2020) Table 21. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2019) Table 22. Global Regenerative Therapies for Osteoarthritis by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Regenerative Therapies for Osteoarthritis Product Solution and Service Table 25. Date of Enter into Regenerative Therapies for Osteoarthritis Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 28. Global Regenerative Therapies for Osteoarthritis Market Size Share by Type (2015-2020) Table 29. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2021-2026) Table 30. Global Regenerative Therapies for Osteoarthritis Market Size Share by Application (2015-2020) Table 31. Global Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 32. Global Regenerative Therapies for Osteoarthritis Market Size Share by Application (2021-2026) Table 33. North America Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 34. North America Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 35. North America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 36. North America Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 37. North America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 38. North America Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 39. Europe Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 41. Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 42. Europe Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 43. Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 44. Europe Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 45. China Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 46. China Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 47. China Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 48. China Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 49. China Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 50. China Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 51. Japan Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 53. Japan Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 54. Japan Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 55. Japan Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 56. Japan Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 59. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 61. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 63. India Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 64. India Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 65. India Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 66. India Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 67. India Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 68. India Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 69. Central & South America Key Players Regenerative Therapies for Osteoarthritis Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Regenerative Therapies for Osteoarthritis Market Share (2019-2020) Table 71. Central & South America Regenerative Therapies for Osteoarthritis Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Regenerative Therapies for Osteoarthritis Market Share by Type (2015-2020) Table 73. Central & South America Regenerative Therapies for Osteoarthritis Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Regenerative Therapies for Osteoarthritis Market Share by Application (2015-2020) Table 75. Acelity Company Details Table 76. Acelity Business Overview Table 77. Acelity Product Table 78. Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 79. Acelity Recent Development Table 80. Mesoblast Company Details Table 81. Mesoblast Business Overview Table 82. Mesoblast Product Table 83. Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 84. Mesoblast Recent Development Table 85. Nuo Therapeutics Company Details Table 86. Nuo Therapeutics Business Overview Table 87. Nuo Therapeutics Product Table 88. Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 89. Nuo Therapeutics Recent Development Table 90. Astellas Pharma Company Details Table 91. Astellas Pharma Business Overview Table 92. Astellas Pharma Product Table 93. Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 94. Astellas Pharma Recent Development Table 95. Organovo Company Details Table 96. Organovo Business Overview Table 97. Organovo Product Table 98. Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 99. Organovo Recent Development Table 100. Orgenesis Company Details Table 101. Orgenesis Business Overview Table 102. Orgenesis Product Table 103. Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 104. Orgenesis Recent Development Table 105. Sanofi Company Details Table 106. Sanofi Business Overview Table 107. Sanofi Product Table 108. Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 109. Sanofi Recent Development Table 110. Athersys Business Overview Table 111. Athersys Product Table 112. Athersys Company Details Table 113. Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 114. Athersys Recent Development Table 115. Takeda Company Details Table 116. Takeda Business Overview Table 117. Takeda Product Table 118. Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 119. Takeda Recent Development Table 120. Cytori Therapeutics Company Details Table 121. Cytori Therapeutics Business Overview Table 122. Cytori Therapeutics Product Table 123. Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2015-2020) (Million US$) Table 124. Cytori Therapeutics Recent Development Table 125. Research Programs/Design for This Report Table 126. Key Data Information from Secondary Sources Table 127. Key Data Information from Primary Sources List of Figures Figure 1. Global Regenerative Therapies for Osteoarthritis Market Share by Type: 2020 VS 2026 Figure 2. Cell Therapy Features Figure 3. Tissue Engineering Features Figure 4. Gene Therapy Features Figure 5. Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Ambulatory Surgical Centers Case Studies Figure 8. Orthopaedic Clinics Case Studies Figure 9. Research Institutes Case Studies Figure 10. Regenerative Therapies for Osteoarthritis Report Years Considered Figure 11. Global Regenerative Therapies for Osteoarthritis Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Regenerative Therapies for Osteoarthritis Market Share by Regions: 2020 VS 2026 Figure 13. Global Regenerative Therapies for Osteoarthritis Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Regenerative Therapies for Osteoarthritis Market Share by Players in 2019 Figure 16. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Regenerative Therapies for Osteoarthritis Revenue in 2019 Figure 18. North America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Acelity Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Acelity Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 27. Mesoblast Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Mesoblast Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 29. Nuo Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Nuo Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 31. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Astellas Pharma Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 33. Organovo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Organovo Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 35. Orgenesis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Orgenesis Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Sanofi Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 39. Athersys Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Athersys Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 41. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Takeda Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 43. Cytori Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Cytori Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2015-2020) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed

Acelity Mesoblast Nuo Therapeutics Astellas Pharma Organovo Orgenesis Sanofi Athersys Takeda Cytori Therapeutics